Volitionrx Ltd
VNRX- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000093314
No open-market purchases or sales by Volitionrx Ltd insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Volitionrx Ltd as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −1 vs. Q3 2021
- Shares held
- 5.95M
- −211.7K (−3.4%) vs. Q3 2021
- Total value
- $18.7M
- −$414.7K (−2.2%) vs. Q3 2021
- New holders
- 3
- 7 more added
- Sold out
- 4
- 12 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VNRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $2.61M |
| Q1 2026 | 31 | $4.52M |
| Q4 2025 | 28 | $4.13M |
| Q3 2025 | 33 | $17.7M |
| Q2 2025 | 29 | $18.2M |
| Q1 2025 | 25 | $12.0M |
| Q4 2024 | 27 | $11.2M |
| Q3 2024 | 22 | $10.5M |
| Q2 2024 | 27 | $4.84M |
| Q1 2024 | 24 | $5.89M |
| Q4 2023 | 28 | $4.56M |
| Q3 2023 | 30 | $4.35M |
| Q2 2023 | 34 | $8.99M |
| Q1 2023 | 38 | $12.2M |
| Q4 2022 | 34 | $15.1M |
| Q3 2022 | 34 | $8.02M |
| Q2 2022 | 31 | $12.2M |
| Q1 2022 | 34 | $18.3M |
| Q4 2021 | 37 | $18.7M |
| Q3 2021 | 39 | $19.2M |
| Q2 2021 | 47 | $21.4M |
| Q1 2021 | 57 | $33.0M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Volitionrx Ltd; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Group One Trading, L.P. | 150 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 5 | $0 | 0.00% | −26−83.9% | Reduced |
| Wells Fargo & Company | 225 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 347 | $1.09K | 0.00% | −46−11.7% | Reduced |
| Total Clarity Wealth Management, Inc. | 720 | $2.00K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 1,000 | $3.00K | 0.00% | +1,000 | New |
| Bank of America Corp | 1,544 | $5.00K | 0.00% | −1,054−40.6% | Reduced |
| UBS Group AG | 1,876 | $6.00K | 0.00% | 00.0% | Unchanged |
| Founders Capital Management | 3,000 | $9.00K | 0.01% | 00.0% | Unchanged |
| CarsonAllaria Wealth Management, Ltd. | 2,840 | $9.00K | 0.01% | +2,840 | New |
| Advisor Group Holdings, Inc. | 3,520 | $11.0K | 0.00% | −12,800−78.4% | Reduced |
| Tower Research Capital LLC (TRC) | 3,954 | $12.0K | 0.00% | +3,854+3,854.0% | Added |
| Credit Agricole S A | 4,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Hartford Financial Management Inc. | 5,000 | $16.0K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 6,000 | $19.0K | 0.00% | +6,000 | New |
| Simplex Trading, LLC | 8,677 | $27.0K | 0.00% | +7,875+981.9% | Added |
| Citadel Advisors LLC | 10,938 | $34.0K | 0.00% | −8,137−42.7% | Reduced |
| Renaissance Technologies LLC | 11,300 | $35.0K | 0.00% | −117,400−91.2% | Reduced |
| Charles Schwab Investment Management Inc | 15,384 | $49.0K | 0.00% | 00.0% | Unchanged |
| Garrison Bradford & Associates Inc | 15,500 | $49.0K | 0.04% | 00.0% | Unchanged |
| Ergoteles LLC | 15,898 | $50.0K | 0.00% | −118,202−88.1% | Reduced |
| Creative Planning | 16,160 | $51.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 21,828 | $69.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 22,385 | $70.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 29,539 | $93.0K | 0.00% | +26,379+834.8% | Added |
| Spectrum Asset Management, Inc. (NB/CA) | 55,596 | $175.0K | 0.05% | 00.0% | Unchanged |
| Millennium Management LLC | 62,622 | $197.0K | 0.00% | −715−1.1% | Reduced |
| Northern Trust Corp | 63,219 | $199.0K | 0.00% | 00.0% | Unchanged |
| Cowen Prime Advisors LLC | 64,600 | $203.0K | 0.07% | +2,400+3.9% | Added |
| Susquehanna International Group, LLP | 76,950 | $242.0K | 0.00% | +6,375+9.0% | Added |
| State Street Corp | 104,823 | $329.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 241,100 | $757.0K | 0.01% | −25,000−9.4% | Reduced |
| Geode Capital Management, LLC | 269,487 | $846.0K | 0.00% | −1,333−0.5% | Reduced |
| Morgan Stanley | 469,553 | $1.48M | 0.00% | −112,956−19.4% | Reduced |
| Vanguard Group Inc | 509,570 | $1.60M | 0.00% | −2,188−0.4% | Reduced |
| BlackRock Inc. | 542,218 | $1.70M | 0.00% | +4,867+0.9% | Added |
| Lagoda Investment Management, L.P. | 3,283,913 | $10.3M | 4.89% | +240,569+7.9% | Added |
| HRT Financial LP | 0 | $0 | 0.00% | −65,570−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −29,539−100.0% | Sold out |
| MTM Investment Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Brewin Dolphin Ltd | 0 | $0 | 0.00% | −8,885−100.0% | Sold out |
| Rinet Co LLC | – | – | – | – | Not filed |